Sansone et al v. Sanofi S.A. et al
Consolidated
Lead case: 9:20-md-02924
Lead case: 9:20-md-02924
| Florida Southern District Court | |
| Judge: | Robin L Rosenberg |
| Case #: | 9:20-cv-80510 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | 28:1332 Diversity-Personal Injury |
| Case Filed: | Mar 26, 2020 |
| Terminated: | Mar 27, 2020 |
| Case in other court: | New York Northern, 1:20-cv-00239 |
| Last checked: Tuesday Sep 22, 2020 6:26 AM EDT |
|
Defendant
Boehringer Ingelheim Pharmaceuticals, Inc.
|
|
|
Defendant
Chattem Inc.
|
|
|
Defendant
GlaxoSmithKline LLC
|
|
|
Defendant
Sanofi S.A.
|
|
|
Defendant
Sanofi U.S. Services Inc.
|
|
|
Defendant
Sanofi-Aventis U.S. LLC
|
|
|
Plaintiff
Anna Sansone
|
Represented By
|
|
Plaintiff
Thomas Sansone
|
Represented By
|
| Docket last updated: 11 hours ago |
| Thursday, September 28, 2023 | ||
| 15 | 15
order
MDL 2924 Final Judgment
Thu 09/28 2:37 PM
RULE 58 FINAL JUDGMENT. Signed by Judge Robin L. Rosenberg on 9/26/2023. See attached document for full details. (nwn) |
|
| Thursday, June 30, 2022 | ||
| 14 | 14
cmp
Amended Complaint/Amended Notice of Removal
Thu 06/30 5:30 PM
Third AMENDED COMPLAINT against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Promeco, S.A. de C.V., Boehringer Ingelheim USA Corporation, Chattem Inc., GlaxoSmithKline (America) Inc., GlaxoSmithKline LLC, GlaxoSmithKline PLC, Sanofi S.A., Sanofi U.S. Services Inc., Sanofi-Aventis U.S. LLC, Walgreen Co., Walgreens Boots Alliance, Inc., Walmart Inc. f/k/a Wal-Mart Stores, Inc., filed by Thomas Sansone, Anna Sansone.(Bogdan, Rosemarie) |
|
| Thursday, January 06, 2022 | ||
| 13 | 13
notice
Notice of Change of Address, Email or Law Firm Name
Thu 01/06 1:34 PM
NOTICE of Change of Address, Email or Law Firm Name by Rosemarie Riddell Bogdan (Bogdan, Rosemarie) |
|
| Friday, December 03, 2021 | ||
| 12 | 12
8
pgs
cmp
Amended Complaint/Amended Notice of Removal
Fri 12/03 3:28 PM
Second AMENDED COMPLAINT against Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Promeco, S.A. de C.V., Boehringer Ingelheim USA Corporation, Chattem Inc., GlaxoSmithKline LLC, Walgreen Co., Walgreens Boots Alliance, Inc., Walmart Inc. f/k/a Wal-Mart Stores, Inc., Patheon Manufacturing Service LLC, GlaxoSmithKline, filed by Thomas Sansone, Anna Sansone.(Bogdan, Rosemarie) |
|
| Tuesday, October 13, 2020 | ||
| 11 | 11
cmp
MDL Amended Complaint
Tue 10/13 10:14 AM
First MDL AMENDED COMPLAINT Thomas Sansone and Anna Sansone against Boehringer Ingelheim Pharmaceuticals, Inc., Chattem Inc., GlaxoSmithKline LLC, Sanofi S.A., Sanofi U.S. Services Inc., Sanofi-Aventis U.S. LLC, Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Promeco, S.A. de C.V., GlaxoSmithKline (America) Inc., Walgreen Co., Walgreens Boots Alliance, Inc., Walmart Inc. f/k/a Wal-Mart Stores, Inc., GlaxoSmithKline PLC, filed by Anna Sansone, Thomas Sansone.(Bogdan, Rosemarie) |
|
|
Att: 1
Civil Cover Sheet
|
||
| Thursday, April 09, 2020 | ||
| 10 | 10
service
Summons Issued
Thu 04/09 1:16 PM
Summons Issued as to Sanofi S.A. (mc) |
|
| Friday, April 03, 2020 | ||
| 9 | 9
cmp
Amended Complaint
Fri 04/03 1:10 PM
AMENDED COMPLAINT against Boehringer Ingelheim Pharmaceuticals, Inc., Chattem Inc., GlaxoSmithKline LLC, Sanofi S.A., Sanofi U.S. Services Inc., Sanofi-Aventis U.S. LLC, filed by Anna Sansone, Thomas Sansone.(Bogdan, Rosemarie) |
|
|
Att: 1
Summon(s) Sanofi S.A.
|
||
| Friday, March 27, 2020 | ||
| 8 | 8
order
Administrative Order
Fri 03/27 3:35 PM
ORDER OF CONSOLIDATION AND ADMINISTRATIVE CLOSE-OUT. Signed by Judge Robin L. Rosenberg on 3/27/2020. See attached document for full details. (mc) |
|
| Thursday, March 26, 2020 | ||
| 7 | 7
transfer
MDL Tag-Along/Transfer In Case Receipt
Thu 03/26 10:18 AM
MDL Transfer In Case Receipt from Northern District of New York. Case Number 1:20-cv-00239 with documents 1-4. Assigned FLSD Case Number 9:20-cv-80510-RLR on 3/26/2020. Re: FLSD MDL Case Number 9:20-md-02924-RLR. (mc) |
|
| 6 | 6
order
Clerk's Notice of Judge Assignment and Optional Consent
Thu 03/26 10:11 AM
Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg. (mc) |
|
| 5 | 5
transfer
Case Transferred In - District Transfer - CV - NO FEE
Thu 03/26 10:09 AM
Case transferred in from New York Northern; Case Number 1:20-cv-00239. Electronic file including transfer order and docket sheet received. .(mc). |
|
| 4 | 4
order
MDL Conditional Transfer Order
Thu 03/26 8:51 AM
JPMDL Conditional Transfer Order #6. Opposition period has expired with no objections filed. ORDER TRANSFERRING CASE to Southern District of Florida for inclusion into MDL-2924 ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION. Case to be assigned to the Hon. Robin L. Rosenberg, U.S. District Judge. (plp) |
|
| Wednesday, March 04, 2020 | ||
| 3 | 3
G.O. 25 FILING ORDER ISSUED: Initial Conference set for 6/3/2020 11:00 AM in Syracuse before Magistrate Judge Therese Wiley Dancks. Civil Case Management Plan must be filed and Mandatory Disclosures are to be exchanged by the parties on or before 5/27/2020. All conferences are conducted by telephone. Plaintiff's attorney will initiate the call (unless the Court directs differently) and shall contact Judge Dancks' Chambers at 315-234-8618 (a dedicated line solely for telephone conferences) once all parties are on the line. Counsel may use a teleconferencing service for assistance initiating conference calls to the Court. For cases involving pro se parties, the Court will initiate the call for the Rule 16 Conference. Pro se parties are instructed to provide the Court with a telephone number where they may be reached for a conference call. (Pursuant to Local Rule 26.2, mandatory disclosures are to be exchanged among the parties but are NOT to be filed with the Court.) (mgh)
|
|
| 2 | 2
Summons Issued as to Boehringer Ingelheim Pharmaceuticals, Inc., Chattem Inc., GlaxoSmithKline, LLC., Sanofi S.A., Sanofi US Services Inc., Sanofi-Aventis U.S. LLC.(mgh)
|
|
|
Att: 1
Summons Issued as to Sanofi-Aventis U.S. LLC,
|
||
|
Att: 2
Summons Issued as t o Sanofi US Services, Inc.,
|
||
|
Att: 3
Summons Issued as to Chattem, Inc.,
|
||
|
Att: 4
Summons Issued as to Boehringer Ingelheim Pharmaceuticals, Inc.,
|
||
|
Att: 5
Summons Issued as to GlaxoSmithKline, LLC
|
||
| Tuesday, March 03, 2020 | ||
| 1 | 1
COMPLAINT against Boehringer Ingelheim Pharmaceuticals, Inc., Chattem Inc., GlaxoSmithKline, LLC., Sanofi S.A., Sanofi US Services Inc., Sanofi-Aventis U.S. LLC. (Filing fee $400 receipt number 5048870) filed by Anna Sansone, Thomas Sansone.(mgh)
|
|
|
Att: 1
Civil Cover Sheet
|
||